100% Free — No Credit Card

Get One Free Biotech Trading Signal Every Week

Our AI analyzes SEC filings, insider trades, and FDA catalysts — then delivers one actionable signal straight to your inbox.

Free forever • No credit card • Unsubscribe anytime

Here's a real example of what you'll receive

VKTX

BULLISHViking Therapeutics

Conviction 91/100

Drug VK2735

Entry $14.10

Peak $31.20

Outcome +121%

Catalyst Phase 2 data readout

Evidence chain (5 signals converged)

8-K FILING

Catalyst Detection— Phase 2 topline data readout announced — timing language indicated high confidence in results

FORM 4

Insider Activity— Zero insider selling + multiple open-market buys by C-suite over 6 months

FDA

Regulatory Tailwind— Fast Track designation granted — signals FDA priority and expedited review

CLINICAL

Phase 1 Data— ~15% mean body weight reduction, dose-dependent response, competitive vs tirzepatide

MARKET

TAM Validation— $100B+ obesity/GLP-1 market validated — any credible entrant reprices significantly

This signal was generated from real SEC EDGAR filings on Feb 27, 2024. Read the full case study →

Want signals like this in your inbox every week?

Free forever • No credit card • Unsubscribe anytime

Join our Alpha Network partners

SentinexVerikalCycoraInvestPilot Pro